Tumor-associated antigens identification, characterization, and clinical applications /

Offering a comprehensive overview of the topic, this ready reference and handbook reviews current knowledge of TAAs, their subclasses, and pinpoints their application areas in medicine. In addition, it emphasizes target identification procedures, the need for an accurate and thorough analysis of the...

Full description

Saved in:
Bibliographic Details
Corporate Authors: Wiley InterScience (Online service)
Group Author: Gires, Olivier.; Seliger, Barbara.
Published:
Literature type: Electronic eBook
Language: English
Subjects:
Online Access: http://onlinelibrary.wiley.com/book/10.1002/9783527625970
Summary: Offering a comprehensive overview of the topic, this ready reference and handbook reviews current knowledge of TAAs, their subclasses, and pinpoints their application areas in medicine. In addition, it emphasizes target identification procedures, the need for an accurate and thorough analysis of the function of TAAs, and their validation in clinical settings. The whole is rounded off with an overview of currently approved therapeutic antibodies. The result is a must-have for biologists and oncologists in science, clinics and industry.
Carrier Form: 1 online resource (xxi, 362 pages) : illustrations
Bibliography: Includes bibliographical references and index.
ISBN: 9783527625970
3527625976
9783527625987 (electronic bk.)
3527625984 (electronic bk.)
Index Number: QR188
CLC: R730.3
Contents: Tumor-Associated Antigens : Identification, Characterization, and Clinical Applications; Contents; List of Contributors; Part One Tumor-associated Antigens (TAAs): Subclasses of TAAs; 1 T Cell Antigens in Cancer; 2 Human Tumor Antigens as Targets of Immunosurveillance and Candidates for Cancer Vaccines; Part Two Methods to Detect TAAs; 3 Humoral Immune Responses against Cancer Antigens: Serological Identification Methods. Part I: SEREX; 4 Humoral Immune Responses against Cancer Antigens: Serological Identification Methods. Part II: Proteomex and AMIDA; 5 cDNA and Microarray-based Technologies.